Drug Shortage Report for MYLAN-NAPROXEN/ESOMEPRAZOLE MR

Last updated on 2019-05-23 History
Report ID 13528
Drug Identification Number 02443449
Brand name MYLAN-NAPROXEN/ESOMEPRAZOLE MR
Common or Proper name NAPROXEN/ESOMEPRAZOLE MR
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE NAPROXEN
Strength(s) 20MG 500MG
Dosage form(s) TABLET (IMMEDIATE AND DELAYED-RELEASE)
Route of administration ORAL
Packaging size 60BT
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-05-15
Actual start date
Estimated end date 2019-05-22
Actual end date 2019-05-22
Shortage status Resolved
Updated date 2019-05-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v65 2019-04-03 English Compare
v64 2019-03-08 French Compare
v63 2019-03-08 English Compare
v62 2019-03-05 French Compare
v61 2019-03-05 English Compare
v60 2019-02-21 French Compare
v59 2019-02-21 English Compare
v58 2019-01-18 French Compare
v57 2019-01-18 English Compare
v56 2019-01-08 French Compare
v55 2019-01-08 English Compare
v54 2018-12-06 English Compare
v53 2018-12-05 French Compare
v52 2018-12-05 English Compare
v51 2018-11-30 French Compare
v50 2018-11-30 English Compare
v49 2018-11-20 French Compare
v48 2018-11-20 English Compare
v47 2018-10-16 French Compare
v46 2018-10-16 English Compare

Showing 21 to 40 of 85